Skip to main content
SpringerLink
Log in

Amgen has announced that out-of-pocket copayments for cancer patients receiving panitumumab [Vectibix] will be capped

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Amgen.Amgen Introduces Comprehensive Financial Assistance Programs for Cancer Patients. Media Release: 28 Sep 2006. Available from: URL: http://www.amgen.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amgen has announced that out-of-pocket copayments for cancer patients receiving panitumumab [Vectibix] will be capped. Pharmacoecon. Outcomes News 514, 10 (2006). https://doi.org/10.2165/00151234-200605140-00030

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605140-00030

Keywords

Search

Navigation